Biohaven Ltd.
Clinical-stage biopharma developing drugs for neuroscience, immunology, and oncology.
BHVN | NYSE
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 215 CHURCH STREET, 6510 NEW HAVEN
- Website:
- https://www.biohaven.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Biohaven Ltd. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of treatments for diseases with high unmet medical needs. Building upon the legacy of success from the team that developed the migraine treatments Nurtec® ODT and Zavzpret® (subsequently acquired by Pfizer), the company now advances a diverse pipeline of late- and early-stage drug candidates. Its primary therapeutic areas of focus include neuroscience, immunology, and oncology. Biohaven leverages proprietary drug development platforms and proven clinical execution expertise to develop innovative medicines for a broad range of rare and common diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Biohaven Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Biohaven Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Biohaven Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
